Limba
Romanian
Romanian
English|
Belantamab (Anti-TNFRSF17 / BCMA / CD269), 1mg*25
19.336,31 RON
SKU
SKM_A2328_1mg*25
Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.
| Price | 16.249,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD. |
